Expert Interview
Discussing the potential of AT-GAA (cipaglucosidase alfa/miglustat) in treating Pompe Patients, with a focus on the Propel study results
Ticker(s): FOLDInstitution: Portland VA Medical Center
- Private practice neurologist
- Manages over 100 patients for epilepsy
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
